Eli Lilly Launches Open Letter about Mounjaro® and Zepbound® Use
Lilly's Open Letter on Tirzepatide Medicines: Mounjaro and Zepbound should not be used for cosmetic weight loss. Patient safety is top priority.
Dyslipidemia News & Breaking Stories
Get Weekly News Updates
Subscribe to SHUT Newsletter and be up to date with the current events. Be informed, don't settle for fake news.